Teal background image.

Governor Hochul Announces New York’s First Cell And Gene Therapy Hub At Roswell Park Comprehensive Cancer Center In Buffalo

$98 Million Cell and Gene Therapy Manufacturing Facility Will Support Research and Development of Life-Saving Technologies Including Cancer-Fighting Cell Therapies

New Hub Will Also Support Efforts to Attract Leading Life Science Companies and New Jobs to New York

Governor Announced Two Cell and Gene Therapy Hubs as Part of State of the State Vision to Build New York’s Fast-Growing Life Science Sector

Governor Kathy Hochul today announced that New York's first cell and gene therapy hub will be housed at Roswell Park Comprehensive Cancer Center in Buffalo, Erie County. The $98 million center will help to support the research and development of life-saving therapies at Roswell, significantly grow its well-established research capabilities, and establish Roswell as one of the premier cell therapy discovery and production institutions in the nation and catalyze the growth of the cell and gene therapy sector in western NY. The expansion also realizes Governor Hochul’s 2023 State of the State commitment to establish an Upstate cell and gene therapy hub and bolster the state’s leadership in the fast-growing life science sector.

“The future of medicine is in cell and gene therapy and this new hub at Roswell Park Comprehensive Care Center will put Western New York – and all of New York State – at the cutting edge of life-saving treatments and therapies,” Governor Hochul said. “In my State of the State address, I committed to investing in fast-growing sectors like the life sciences, and thanks to a $30 million state investment, Roswell’s new facility will help to solidify our state’s future in the field, create 21st century jobs, and provide hope to generations of New Yorkers who rely on these critical treatments.” 

Empire State Development will invest $30 million to assist in expanding the current cell and gene therapy research capacity at Roswell’s Therapeutic Cell Production Facility from six to 20 specialized clean rooms, making it the largest academic cell and gene therapy research and manufacturing facility in the United States. The new facility will streamline every step of the cell therapy development process, shortening the path from research to production. It will encourage the growth of startup companies commercializing these therapies, grow private investment, strengthen the state’s innovation-focused talent pool, and attract partnerships with biopharma companies.

Read the full press release here.